TRCT
CNTB

Tower Research Capital (TRC)’s Connect Biopharma Holdings CNTB Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,398
Closed -$9K – 5863
2022
Q4 		$9K Sell
10,398
-5,812
-36% -$4.79K ﹤0.01% 4177
2022
Q3 		$21K Sell
16,210
-615
-4% -$739 ﹤0.01% 3889
2022
Q2 		$15K Buy
16,825
+15,584
+1,256% +$23K ﹤0.01% 4061
2022
Q1 		$4K Buy
+1,241
New +$5.24K ﹤0.01% 5187

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tower Research Capital (TRC)'s CNTB Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Connect Biopharma Holdings (CNTB) in Q1 2023, closing a stake of 10,398 shares — an estimated $9K sold.

Tower Research Capital (TRC) first reported a position in CNTB in Q1 2022 and held it in 4 quarters. The position peaked at $21K in Q3 2022. 16 funds tracked by Wall St. Rank hold CNTB as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Connect Biopharma Holdings position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 10,398 Connect Biopharma Holdings shares in Q1 2023, an estimated $9K.
  • Tower Research Capital (TRC) first reported a position in Connect Biopharma Holdings in Q1 2022 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s Connect Biopharma Holdings position peaked at $21K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.